Respiri Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
8,212.00
3,008.60
4,502.10
1,562.90
2,418.40
Total Accounts Receivable
83.90
69.90
80.40
866.20
118.80
Inventories
1,064.50
1,342.40
-
-
-
Other Current Assets
494.20
138.00
73.80
66.20
109.80
Total Current Assets
9,854.60
4,558.80
4,656.30
2,495.30
2,647.00
Net Property, Plant & Equipment
99.40
77.70
53.00
19.90
11.00
Long-Term Note Receivable
0.30
-
-
-
-
Intangible Assets
650.00
548.50
368.90
123.00
-
Other Assets
-
-
-
3.10
3.00
Total Assets
10,604.20
5,185.00
5,078.20
2,641.20
2,661.00
Accounts Payable
509.70
386.40
435.80
268.50
503.30
Other Current Liabilities
1,018.10
898.20
606.40
575.20
506.80
Total Current Liabilities
1,527.80
1,284.60
1,042.30
843.70
1,010.10
Total Liabilities
1,527.80
1,284.60
1,042.30
843.70
1,010.10
Common Equity (Total)
9,076.40
3,900.40
4,035.90
1,797.60
1,650.80
Total Shareholders' Equity
9,076.40
3,900.40
4,035.90
1,797.60
1,650.80
Total Equity
9,076.40
3,900.40
4,035.90
1,797.60
1,650.80
Liabilities & Shareholders' Equity
10,604.20
5,185.00
5,078.20
2,641.20
2,661.00

About Respiri

View Profile
Address
446 Collins Street
Melbourne Victoria (VIC) 3000
Australia
Employees -
Website http://www.respiri.com.au
Updated 07/08/2019
Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. It operates through the Australia and Israel segments.